NICE Ltd. (NASDAQ: NICE) VP granted 5,000 options vesting 2027-2030

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

NICE Ltd. reported that VP of Corporate Finance Dayan Udi Yehuda received a grant of 5,000 stock options linked to 5,000 Ordinary Shares. The options have an exercise price of 0.3211 per share and expire on April 1, 2032. According to the disclosure, the stock option will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030. This is a compensation-related award, not an open-market purchase or sale, and after the grant he holds 5,000 options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dayan Udi Yehuda

Role VP, Corporate Finance

Type	Security	Shares	Price	Value
Grant/Award	Options	5,000	$0.00	--

Holdings After Transaction: Options — 5,000 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Options granted: 5,000 options Underlying shares: 5,000 Ordinary Shares Exercise price: 0.3211 per share +3 more

6 metrics

Options granted 5,000 options Grant to VP, Corporate Finance on April 1, 2026

Underlying shares 5,000 Ordinary Shares Shares underlying granted options

Exercise price 0.3211 per share Conversion or exercise price of options

Expiration date April 1, 2032 Option expiration

Post-grant derivative holdings 5,000 options Total options held following transaction

Vesting schedule 4 equal installments Vests on April 1 of 2027, 2028, 2029, 2030

Key Terms

stock option, grant/award acquisition, Ordinary Shares, exercise price, +1 more

5 terms

stock option financial

"The stock option will vest in substantially equal installments"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"transaction_action: grant/award acquisition"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: 0.3211"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2032-04-01T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

04/01/2026 - 06:04 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dayan Udi Yehuda

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Corporate Finance

2a. Foreign Trading Symbol
[NICE.TA]

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options	$0.3211	04/01/2026		A		5,000		⁽¹⁾	04/01/2032	Ordinary Shares	5,000	$0	5,000	D

Explanation of Responses:

1. The stock option will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030.

	/s/ Alon Levy, Attorney-in-Fact for Udi Dayan Yehuda	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the latest Form 4 for NICE (NICE) report?

The Form 4 reports that VP of Corporate Finance Dayan Udi Yehuda received a grant of 5,000 stock options. These options relate to 5,000 NICE Ordinary Shares and represent a compensation award, not an open-market stock purchase or sale.

How many stock options were granted to NICE executive Dayan Udi Yehuda?

Dayan Udi Yehuda was granted 5,000 stock options linked to 5,000 NICE Ordinary Shares. The grant increases his derivative holdings to 5,000 options, all held directly, and reflects equity-based compensation rather than a market transaction in existing shares.

What is the exercise price and expiration date of the NICE options grant?

The granted stock options have an exercise price of 0.3211 per share and expire on April 1, 2032. This means the executive can choose to exercise the options at 0.3211 per share any time before that expiration date, subject to vesting.

When do the NICE (NICE) stock options granted to the VP vest?

The stock option will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030. This four-year vesting schedule means portions of the 5,000 options become exercisable over time.

Is the NICE Form 4 transaction a stock purchase or sale?

No, the Form 4 shows a grant of 5,000 stock options, not a market purchase or sale of shares. The transaction is classified as a grant or award acquisition, providing the executive with options to buy Ordinary Shares in the future if exercised.

How many NICE options does the reporting person hold after this grant?

After the transaction, the reporting person holds 5,000 stock options directly. These options all relate to NICE Ordinary Shares and reflect the total derivative position shown in this Form 4, with no additional derivative holdings listed in the filing excerpt.